UTEP Faculty Profiles

Main Content

Weiqin Lu

Professor
Pharmacy

Office Building: Campbell Building
Office Room: 512
Phone: (915) 747-8542
Email: wlu2@utep.edu

Expertise: See Research Profile in Expertise Connector

Bio

No info available.

Awards and Honors

UTEP Postdoctoral Career Transition Program in Cancer Research - CPRIT (08/01/2023-08/31/2023)
STARs Award - The University of Texas System (09/01/2022)
The Basic Science Research Award - Department of Medicine at Stony Brook University (01/01/2021-12/31/2021)
Idea Award, Peer-Reviewed Cancer Research Program - Department of Defense (01/01/2020-12/31/2020)
NIDDK R01 Award - NIH (01/01/2020-12/31/2020)
R01 - NCI (01/01/2020-12/31/2020)
Research Scholar Award - American Cancer Society (01/01/2020-12/31/2020)
Pilot Project Grant - Department of Medicine, Stony Brook University (01/01/2020)
NIH High Priority R56 Award - NIH (09/01/2019-09/30/2019)
Finalist in Faculty Category-13th Annual Women in Medicine Research Day - Stony Brook University School of Medicine (03/01/2019-03/31/2019)
SUNY Central Award - Stony Brook University (01/01/2019-01/31/2019)
Finalist in Faculty Category-11th Annual Women in Medicine Research Day - Stony Brook University School of Medicine (03/01/2017-03/31/2017)
Pilot Project Grant - Department of Medicine, Stony Brook University (01/01/2017)
Young Investigator Award - American Pancreatic Association (11/15/2015)
Khalifa Bin Zayed Al Nahyan Research Award - MD Anderson Cancer Center (09/01/2014)
Khalifa Bin Zayed Al Nahyan Research Award - MD Anderson Cancer Center (09/01/2014)
Predoctoral Fellowship Award - University of Texas-Graduate School of Biomedical Sciences, Houston, TX (08/20/2003)

Education

Ph D in Molecular Pathology, University of Texas Health Science Center (2008)

Publications

Early elevations of RAS protein level and activity are critical for the development of PDAC in the context of inflammation. Cancer letters (2024), J Ma, F Gong, Eunja Kim, J X. Du , C Leung, S Qingchun, C D. Logsdon, Y Luo, X Li , Weiqin Lu.
Targeting the FGF19-FGFR4 pathway for cholestatic, metabolic, and cancerous diseases. Journal of internal medicine (2024), X Li , Weiqin Lu, A Kharitonenkov, Y Luo.
Oncogenic KRASG12D Reprograms Lipid Metabolism by Upregulating SLC25A1 to Drive Pancreatic Tumorigenesis. Cancer Research Cancer Research 83 22 (2023), R Zhang, X Peng, J X. Du , R Boohaker, I L. Estevao, B I. Grajeda, Marc B. Cox, Igor C. Almeida, Weiqin Lu.
Methionine restriction sensitizes cancer cells to immunotherapy. Cancer communications (London, England) 43 11 (2023), Weiqin Lu, Y Luo.
Oncogenic KRASG12D reprograms lipid metabolism by upregulating SLC25A1 to drive pancreatic tumorigenesis Cancer Research 83 22 (2023), R. Zhang, X. Peng, J.X. Du, R. Boohaker, I. Estevao, B. Grajeda, Marc B. Cox, Igor C. Almeida, Weiqin Lu.
Differential Effects of Dietary Macronutrients on the Development of Oncogenic KRAS-Mediated Pancreatic Ductal Adenocarcinoma CANCERS 14 11 (2022), Liang Zhu, Juntao Ji, Jianjia Ma, Dan Wang, Muyun Liu, James X. Du, Rong Chen, Wei Hou, James L. Abbruzzese, Craig D. Logsdon, Vincent W. Yang, Yongde Luo, Weiqin Lu.
FGF21 in obesity and cancer: New insights CANCER LETTERS 499 (2021), Weiqin Lu, Xiaokun Li, Yongde Luo.
Pancreatic Tumorigenesis: Oncogenic KRAS and the Vulnerability of the Pancreas to Obesity CANCERS 13 4 (2021), Yongde Luo, Xiaokun Li, Jianjia Ma, James L. Abbruzzese, Weiqin Lu.
Selective killing of cancer cells harboring mutant RAS by concomitant inhibition of NADPH oxidase and glutathione biosynthesis CELL DEATH & DISEASE 12 2 (2021), Muyun Liu, Dan Wang, Yongde Luo, Lianghao Hu, Yawei Bi, Juntao Ji, Haojie Huang, Guoqiang Wang, Liang Zhu, Jianjia Ma, Eunice Kim, Catherine K. Luo, James L. Abbruzzese, Xiaokun Li, Vincent W. Yang, Zhaoshen Li, Weiqin Lu.
The Significance of Mitochondrial Dysfunction in Cancer INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES 21 16 (2020), Yongde Luo, Jianjia Ma, Weiqin Lu.
Emerging Structure-Function Paradigm of Endocrine FGFs in Metabolic Diseases TRENDS IN PHARMACOLOGICAL SCIENCES 40 2 (2019), Yongde Luo, Sheng Ye, Xiaokun Li, Weiqin Lu.
Measurement of Reactive Oxygen Species by Fluorescent Probes in Pancreatic Cancer Cells PANCREATIC CANCER, 3 EDITION 1882 (2019), Yongde Luo, Dan Wang, James L. Abbruzzese, Weiqin Lu.
Obesogenic high-fat diet heightens aerobic glycolysis through hyperactivation of oncogenic KRAS CELL COMMUNICATION AND SIGNALING 17 (2019), Dan Wang, Yawei Bi, Lianghao Hu, Yongde Luo, Juntao Ji, Albert Z. Mao, Craig D. Logsdon, Ellen Li, James L. Abbruzzese, Zhaoshen Li, Vincent W. Yang, Weiqin Lu.
Oncogenic KRAS Reduces Expression of FGF21 in Acinar Cells to Promote Pancreatic Tumorigenesis in Mice on a High-Fat Diet GASTROENTEROLOGY 157 5 (2019), Yongde Luo, Yaying Yang, Muyun Liu, Dan Wang, Feng Wang, Yawei Bi, Juntao Ji, Suyun Li, Yan Liu, Rong Chen, Haojie Huang, Xiaojie Wang, Agnieszka K. Swidnicka-Siergiejko, Tobias Janowitz, Semir Beyaz, Guoqiang Wang, Sulan Xu, Agnieszka B. Bialkowska, Catherine K. Luo, Christoph L. Pin, Guang Liang, Xiongbin Lu, Maoxin Wu, Kenneth R. Shroyer, Robert A. Wolff, William Plunkett, Baoan Ji, Zhaoshen Li, Ellen Li, Xiaokun Li, Vincent W. Yang, Craig D. Logsdon, James L. Abbruzzese, Weiqin Lu.
Transgenic expression of cyclooxygenase-2 in pancreatic acinar cells induces chronic pancreatitis AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY 316 1 (2019), Haojie Huang, Jiaxiang Chen, Lisi Peng, Yao Yao, Defeng Deng, Yang Zhang, Yan Liu, Huamin Wang, Zhaoshen Li, Yan Bi, Ashley N. Haddock, Xianbao Zhan, Weiqin Lu, Craig D. Logsdon, Baoan Ji.

Presentations

Obesity and Pancreatic Cancer (2023), Weiqin Lu.
Revisit Oncogenic KRAS in Pancreatic Cancer Development (2023), Weiqin Lu.
Obesity, ROS, and Pancreatic Cancer (2023), Volume online, Weiqin Lu.
Oncogenic KrasG12D reprograms lipid metabolism by regulating SLC25A1 expression to drive pancreatic tumorigenesis. (2022), Volume FL, Weiqin Lu.
RAS activation in oncogenic KRAS and IKK2 mediated pancreatic ductal adenocarcinoma (2022), Volume Stony Brook, NY, Weiqin Lu.
Oncogenic KrasG12D reprograms lipid metabolism by regulating SLC25A1 expression to drive pancreatic tumorigenesis (2022), Volume Stony Brook, NY, Weiqin Lu.
Pancreatic Cancer and Its Risk Factors (2022), Weiqin Lu.
Obesity and Pancreatic Cancer (2022), Weiqin Lu.
High-Fat Diet and Pancreatic Cancer (2021), Volume Stony Brook University, Weiqin Lu.
Obesity, Inflammation, and Pancreatic Cancer (2021), Weiqin Lu.
Unraveling the Mechanistic Link between Obesity and Pancreatic Cancer (2021), Weiqin Lu.
Mechanistic Link Between Obesity and Pancreatic Cancer (2021), Volume Stony Brook University, Weiqin Lu.
Targeting Redox Metabolism for Pancreatic Cancer Therapy (2021), Volume Stony Brook University, Weiqin Lu.
Unraveling the Mechanistic Link between Obesity and Pancreatic Cancer (2021), Volume Tulane University School of Medicine. , Weiqin Lu.
Pancreatic Tumorigenesis: Oncogenic KRAS and the Vulnerability of the Pancreas to Obesity (2021), Volume The University of Toledo, Weiqin Lu.
Unraveling the Mechanistic Link Between Obesity and PDAC. (2021), Volume Tianjing, China, Weiqin Lu.
High-Fat Diet and Pancreatic Cancer (2020), Volume Stony Brook University Cancer Center, Weiqin Lu.
Unraveling the Mechanistic Link Between High-Fat Diet and Pancreatic Cancer (2020), Volume Department of Medicine, Stony Brook University, Weiqin Lu.
Interplay between Inflammation and Oncogenic KRAS in Pancreatic Tumorigenesis (2020), Volume Stony Brook University, Weiqin Lu.
Impact of High-Fat Diet on Pancreatic Tumorigenesis (2020), Volume Stony Brook University Cancer Center., Weiqin Lu.
The Role of High‐Fat Diet in Pancreatic Cancer Development (2020), Volume The Department of Pharmacological Sciences, Stony Brook University School of Medicine, NY., Weiqin Lu.
Role of Obesity and Inflammation in Pancreatic Cancer Development (2020), Volume Stony Brook University School of Medicine, NY., Weiqin Lu.
Obesogenic High-Fat Diet and Oncogenic KRAS in Pancreatic Tumorigenesis. (2020), Volume Stony Brook University School of Medicine, NY. , Weiqin Lu.
Oncogenic KRAS Reduces Expression of FGF21 to Promote Pancreatic Tumorigenesis. (2019), Volume Jiangxi, China, Weiqin Lu.
Role of NADPH Oxidase in Pancreatic Tumorigenesis (2019), Volume Department of Medicine , Stony Brook University School of Medicine, NY. , Weiqin Lu.

Grants

CPRIT: TREC: Institutional Postdoctoral Training Award

Current/Future Courses

Term	Course	Section
Spring 2025	ESE 6396 - Doctoral Research	21564
Fall 2024	BME 6398 - Dissertation	16399
Fall 2024	BME 6399 - Dissertation	16401
Fall 2024	BME 6194 - Doctoral Research	15972
Fall 2024	BME 6294 - Doctoral Research	16395
Fall 2024	BME 6394 - Doctoral Research	16397
Fall 2024	BME 6494 - Doctoral Research	16404
Fall 2024	BME 6594 - Doctoral Research	16408
Fall 2024	BME 6694 - Doctoral Research	16410
Fall 2024	ESE 6396 - Doctoral Research	16154
Fall 2024	PHAR 6200 - Human Metabolism	18047
Fall 2024	BIOL 5302 - Resrch Biological Science	17909

Past Courses

Select Term:

Term	Course	Section	Syllabus
Spring 2025	ESE 6396 - Doctoral Research	21564
Spring 2024	BME 6394 - Doctoral Research	27066
Spring 2024	PHAR 6303 - Pharmacokinetics & Genomics	24906	Syllabus
Fall 2023	BME 6194 - Doctoral Research	17575
Fall 2023	PHAR 6200 - Human Metabolism	15422	Syllabus
Summer 2023	BME 6394 - Doctoral Research	33242
Summer 2023	BME 6694 - Doctoral Research	33258
Spring 2023	PHAR 6303 - Pharmacokinetics & Genomics	25782

Course Evaluations

Term	Course	Section	Evaluation
Fall 2023	PHAR 6200 - Human Metabolism	15422	Evaluation
Spring 2023	PHAR 6303 - Pharmacokinetics & Genomics	25782	Evaluation

Bio

No info available.

Awards and Honors

UTEP Postdoctoral Career Transition Program in Cancer Research - CPRIT (08/01/2023-08/31/2023)
STARs Award - The University of Texas System (09/01/2022)
The Basic Science Research Award - Department of Medicine at Stony Brook University (01/01/2021-12/31/2021)
Idea Award, Peer-Reviewed Cancer Research Program - Department of Defense (01/01/2020-12/31/2020)
NIDDK R01 Award - NIH (01/01/2020-12/31/2020)
R01 - NCI (01/01/2020-12/31/2020)
Research Scholar Award - American Cancer Society (01/01/2020-12/31/2020)
Pilot Project Grant - Department of Medicine, Stony Brook University (01/01/2020)
NIH High Priority R56 Award - NIH (09/01/2019-09/30/2019)
Finalist in Faculty Category-13th Annual Women in Medicine Research Day - Stony Brook University School of Medicine (03/01/2019-03/31/2019)
SUNY Central Award - Stony Brook University (01/01/2019-01/31/2019)
Finalist in Faculty Category-11th Annual Women in Medicine Research Day - Stony Brook University School of Medicine (03/01/2017-03/31/2017)
Pilot Project Grant - Department of Medicine, Stony Brook University (01/01/2017)
Young Investigator Award - American Pancreatic Association (11/15/2015)
Khalifa Bin Zayed Al Nahyan Research Award - MD Anderson Cancer Center (09/01/2014)
Khalifa Bin Zayed Al Nahyan Research Award - MD Anderson Cancer Center (09/01/2014)
Predoctoral Fellowship Award - University of Texas-Graduate School of Biomedical Sciences, Houston, TX (08/20/2003)

Ph D in Molecular Pathology, University of Texas Health Science Center (2008)

Publications

Early elevations of RAS protein level and activity are critical for the development of PDAC in the context of inflammation. Cancer letters (2024), J Ma, F Gong, Eunja Kim, J X. Du , C Leung, S Qingchun, C D. Logsdon, Y Luo, X Li , Weiqin Lu.
Targeting the FGF19-FGFR4 pathway for cholestatic, metabolic, and cancerous diseases. Journal of internal medicine (2024), X Li , Weiqin Lu, A Kharitonenkov, Y Luo.
Oncogenic KRASG12D Reprograms Lipid Metabolism by Upregulating SLC25A1 to Drive Pancreatic Tumorigenesis. Cancer Research Cancer Research 83 22 (2023), R Zhang, X Peng, J X. Du , R Boohaker, I L. Estevao, B I. Grajeda, Marc B. Cox, Igor C. Almeida, Weiqin Lu.
Methionine restriction sensitizes cancer cells to immunotherapy. Cancer communications (London, England) 43 11 (2023), Weiqin Lu, Y Luo.
Oncogenic KRASG12D reprograms lipid metabolism by upregulating SLC25A1 to drive pancreatic tumorigenesis Cancer Research 83 22 (2023), R. Zhang, X. Peng, J.X. Du, R. Boohaker, I. Estevao, B. Grajeda, Marc B. Cox, Igor C. Almeida, Weiqin Lu.

Presentations

Obesity and Pancreatic Cancer (2023), Weiqin Lu.
Revisit Oncogenic KRAS in Pancreatic Cancer Development (2023), Weiqin Lu.
Obesity, ROS, and Pancreatic Cancer (2023), Volume online, Weiqin Lu.
Oncogenic KrasG12D reprograms lipid metabolism by regulating SLC25A1 expression to drive pancreatic tumorigenesis. (2022), Volume FL, Weiqin Lu.
RAS activation in oncogenic KRAS and IKK2 mediated pancreatic ductal adenocarcinoma (2022), Volume Stony Brook, NY, Weiqin Lu.

CPRIT: TREC: Institutional Postdoctoral Training Award

Current/Future Courses

Term

Spring 2025

Course

ESE 6396 - Doctoral Research

Section

21564

Syllabus

Term

Fall 2024

Course

BME 6398 - Dissertation

Section

16399

Syllabus

Term

Fall 2024

Course

BME 6399 - Dissertation

Section

16401

Syllabus

Term

Fall 2024

Course

BME 6194 - Doctoral Research

Section

15972

Syllabus

Term

Fall 2024

Course

BME 6294 - Doctoral Research

Section

16395

Syllabus

Term

Fall 2024

Course

BME 6394 - Doctoral Research

Section

16397

Syllabus

Term

Fall 2024

Course

BME 6494 - Doctoral Research

Section

16404

Syllabus

Term

Fall 2024

Course

BME 6594 - Doctoral Research

Section

16408

Syllabus

Term

Fall 2024

Course

BME 6694 - Doctoral Research

Section

16410

Syllabus

Term

Fall 2024

Course

ESE 6396 - Doctoral Research

Section

16154

Syllabus

Term

Fall 2024

Course

PHAR 6200 - Human Metabolism

Section

18047

Syllabus

Term

Fall 2024

Course

BIOL 5302 - Resrch Biological Science

Section

17909

Syllabus

Past Courses

Select Term:

Term

Spring 2025

Course

ESE 6396 - Doctoral Research

Section

21564

Syllabus

Term

Spring 2024

Course

BME 6394 - Doctoral Research

Section

27066

Syllabus

Term

Spring 2024

Course

PHAR 6303 - Pharmacokinetics & Genomics

Section

24906

Syllabus

Term

Fall 2023

Course

BME 6194 - Doctoral Research

Section

17575

Syllabus

Term

Fall 2023

Course

PHAR 6200 - Human Metabolism

Section

15422

Syllabus

Term

Summer 2023

Course

BME 6394 - Doctoral Research

Section

33242

Syllabus

Term

Summer 2023

Course

BME 6694 - Doctoral Research

Section

33258

Syllabus

Term

Spring 2023

Course

PHAR 6303 - Pharmacokinetics & Genomics

Section

25782

Syllabus

Term

Fall 2023

Course

PHAR 6200 - Human Metabolism

Section

15422

Evaluation

Term

Spring 2023

Course

PHAR 6303 - Pharmacokinetics & Genomics

Section

25782

Evaluation

FACULTY PROFILES

Quick Links

Weiqin Lu

FACULTY PROFILES

Weiqin Lu

Bio

Education

Scholarly and Creative Activity

Grants

Courses

Course Evaluations